Millennium Management’s Spyre Therapeutics SYRE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q1
Sell
-167,804
Closed -$3.91M 4400
2024
Q4
$3.91M Buy
+167,804
New +$3.91M ﹤0.01% 2149
2024
Q2
Sell
-319,563
Closed -$12.1M 4480
2024
Q1
$12.1M Buy
319,563
+211,077
+195% +$8.01M 0.01% 1378
2023
Q4
$2.33M Buy
108,486
+70,673
+187% +$1.52M ﹤0.01% 2378
2023
Q3
$463K Sell
37,813
-60,316
-61% -$739K ﹤0.01% 3297
2023
Q2
$1.11M Sell
98,129
-51,330
-34% -$578K ﹤0.01% 2863
2023
Q1
$1.08M Buy
149,459
+24,200
+19% +$176K ﹤0.01% 2980
2022
Q4
$1.41M Buy
125,259
+92,672
+284% +$1.04M ﹤0.01% 2918
2022
Q3
$429K Buy
32,587
+11,710
+56% +$154K ﹤0.01% 3949
2022
Q2
$264K Buy
20,877
+3,920
+23% +$49.6K ﹤0.01% 4318
2022
Q1
$975K Buy
16,957
+9,338
+123% +$537K ﹤0.01% 3599
2021
Q4
$905K Sell
7,619
-13,790
-64% -$1.64M ﹤0.01% 3565
2021
Q3
$4.26M Sell
21,409
-318
-1% -$63.2K ﹤0.01% 2338
2021
Q2
$3.78M Buy
21,727
+6,882
+46% +$1.2M ﹤0.01% 2442
2021
Q1
$2.94M Sell
14,845
-3,521
-19% -$697K ﹤0.01% 2542
2020
Q4
$3.61M Buy
18,366
+16,186
+742% +$3.19M ﹤0.01% 2134
2020
Q3
$386 Sell
2,180
-5,158
-70% -$913 ﹤0.01% 2955
2020
Q2
$1.7M Buy
7,338
+6,781
+1,217% +$1.57M ﹤0.01% 2112
2020
Q1
$65K Buy
+557
New +$65K ﹤0.01% 2955
2019
Q3
Sell
-3,035
Closed -$520K 3793
2019
Q2
$520K Buy
3,035
+2,454
+422% +$420K ﹤0.01% 2725
2019
Q1
$117K Sell
581
-254
-30% -$51.2K ﹤0.01% 3287
2018
Q4
$156K Buy
+835
New +$156K ﹤0.01% 3076
2018
Q3
Sell
-19,059
Closed -$5.04M 3767
2018
Q2
$5.04M Buy
19,059
+16,091
+542% +$4.26M 0.01% 1622
2018
Q1
$736K Buy
2,968
+2,415
+437% +$599K ﹤0.01% 2638
2017
Q4
$75K Buy
+553
New +$75K ﹤0.01% 3461
2016
Q4
Sell
-1,438
Closed -$230K 3422
2016
Q3
$230K Sell
1,438
-1,068
-43% -$171K ﹤0.01% 2683
2016
Q2
$304K Buy
+2,506
New +$304K ﹤0.01% 2487